We are live on
!
Find out more
ACM
Apex Capital Management Portfolio holdings
AUM
$4.54B
1-Year Est. Return
1.74%
This Fund
S&P 500
This Quarter
Est. Return
+7.31%
1 Year Est. Return
+1.74%
3 Year Est. Return
+80.63%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.75B
AUM Growth
+$436M
(+13%)
Cap. Flow
+$286M
Cap. Flow
% of AUM
7.63%
Top 10 Holdings %
Top 10 Hldgs %
19.71%
Holding
267
New
24
Increased
137
Reduced
57
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$69.6M |
| 2 |
KS
KapStone Paper and Pack Corp.
KS
|
+$47.7M |
| 3 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$38.4M |
| 4 |
VRNT
Verint Systems
VRNT
|
+$31.2M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$59.3M |
| 2 |
Visteon
VC
|
+$53.5M |
| 3 |
Affiliated Managers Group
AMG
|
+$42.3M |
| 4 |
Helmerich & Payne
HP
|
+$41.8M |
| 5 |
Cullen/Frost Bankers
CFR
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.21% |
| 2 | Consumer Discretionary | 19.42% |
| 3 | Healthcare | 16.62% |
| 4 | Technology | 13.68% |
| 5 | Financials | 4.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Entegris
ENTG
$18.2B
| $30.1M | 0.8% |
2,275,850
+102,949
| +5% | +$1.32M |
|
52
Enanta Pharmaceuticals
ENTA
$366M
| $29.8M | 0.8% |
586,701
+536,451
| +1,068% | +$24M |
|
|
SPLK
53
DELISTED
Splunk Inc
SPLK
| $29.2M | 0.78% |
+495,668
| New | +$30.4M |
|
54
Manhattan Associates
MANH
$11.4B
| $27.3M | 0.73% |
669,225
+39,379
| +6% | +$1.51M |
|
|
BEAV
55
DELISTED
B/E Aerospace Inc
BEAV
| $26.4M | 0.7% |
454,455
-146,493
| -24% | -$8.17M |
|
|
KERX
56
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $26.1M | 0.7% |
1,843,754
+127,784
| +7% | +$1.98M |
|
|
INFA
57
DELISTED
INFORMATICA CORP
INFA
| $25.4M | 0.68% |
666,709
+29,318
| +5% | +$1.05M |
|
58
Hain Celestial
HAIN
$44.8M
| $25.4M | 0.68% |
+435,994
| New | +$23.6M |
|
59
Albemarle
ALB
$13.7B
| $24.9M | 0.66% |
414,128
+10,543
| +3% | +$621K |
|
60
NETSCOUT
NTCT
$2.99B
| $24.3M | 0.65% |
+665,471
| New | +$25.1M |
|
61
Insulet
PODD
$11.8B
| $24.1M | 0.64% |
522,374
+460,875
| +749% | +$19.7M |
|
62
Core Laboratories
CLB
$478M
| $23.9M | 0.64% |
198,240
+1,875
| +1% | +$246K |
|
|
WLL
63
DELISTED
Whiting Petroleum Corporation
WLL
| $23.7M | 0.63% |
2,393
+300
| +14% | +$4.58M |
|
|
NSR
64
DELISTED
Neustar Inc
NSR
| $23.6M | 0.63% |
850,683
+20,053
| +2% | +$527K |
|
65
Yelp
YELP
$1.48B
| $23.6M | 0.63% |
431,660
+7,849
| +2% | +$464K |
|
66
Interactive Brokers
IBKR
$38.6B
| $23.1M | 0.62% |
3,167,492
+320,288
| +11% | +$2.14M |
|
|
TIVO
67
DELISTED
Tivo Inc
TIVO
| $22.5M | 0.6% |
997,597
+31,619
| +3% | +$665K |
|
68
United Therapeutics
UTHR
$25.8B
| $22.1M | 0.59% |
171,029
+7,793
| +5% | +$1M |
|
69
Protolabs
PRLB
$1.89B
| $19.6M | 0.52% |
291,491
+39,939
| +16% | +$2.63M |
|
70
MarketAxess Holdings
MKTX
$5.71B
| $17.8M | 0.47% |
248,484
+23,064
| +10% | +$1.52M |
|
71
Apple
AAPL
$4.52T
| $17.7M | 0.47% |
641,080
-7,112
| -1% | -$193K |
|
72
Microsoft
MSFT
$3.63T
| $15.2M | 0.41% |
327,963
-1,884
| -0.6% | -$88.4K |
|
|
ZU
73
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $14.3M | 0.38% |
610,346
+7,959
| +1% | +$244K |
|
74
Alphabet (Google) Class C
GOOG
$4.55T
| $14.2M | 0.38% |
539,277
-20,335
| -4% | -$546K |
|
75
Cracker Barrel
CBRL
$1.31B
| $14M | 0.37% |
99,391
+23,370
| +31% | +$2.81M |
|
Similar funds
BKBG
CAM
VRS
FMA
KG
NPIT
AIA
EIM
Apex Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Apex Capital Management held 267 positions worth $3.75B, up 13% from $3.32B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Apex Capital Management deployed $286M of net new capital in Q4 2014, opening 24 new positions and adding to 137 existing holdings. Its largest new stake was Universal Health Services: 662,924 shares worth $73.8M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Visteon, an estimated $53.5M trimmed.
- Apex Capital Management's largest Q4 2014 buy was Universal Health Services: 662,924 shares worth $73.8M.
- Apex Capital Management added most to Verint Systems in Q4 2014, an estimated $31.2M increase.
- Apex Capital Management's biggest Q4 2014 reduction was Visteon, cutting an estimated $53.5M.
- Apex Capital Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q4 2014, selling an estimated $59.3M.
- Apex Capital Management's ten largest holdings make up 20% of its $3.75B portfolio in Q4 2014.
- Apex Capital Management opened 24 new positions and closed 17 in Q4 2014.
- Apex Capital Management's portfolio value rose 13% quarter-over-quarter to $3.75B.
Based on Apex Capital Management's 13F filing for Q4 2014, filed 20 Jan 2015.